Optimising Azithromycin Prevention Treatment in COPD to Reduce Exacerbations | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Optimising Azithromycin Prevention Treatment in COPD to Reduce Exacerbations	Chronic Disease, Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, chronic obstructive pulmonary disease, lung disorder, obstructive lung disease, respiratory system disorder	Recruiting	Phase 4	2024-04-03		NCT05772013

19 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Dr Ian B Wilkinson	1
Eramol (UK) Ltd.	1
Imperial College London	220
Liverpool Heart and Chest Hospital NHS Foundation Trust	13
Liverpool School of Tropical Medicine	30
National Institute for Health Research, United Kingdom	75
Newcastle University	32
NHS Greater Glasgow and Clyde	44
NHS Sunderland Clinical Commissioning Group	1
Nottingham City Hospital	1
Red Graphic	1
Royal Brompton & Harefield NHS Foundation Trust	38
Sealed Envelope Ltd.	1
Swansea University	15
University College London Hospitals	51
University of Aberdeen	37
University of Cambridge	80
University of East Anglia	13
WGK Clinical Services Ltd.	1

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Cambridge University Hospital NHS Trust, Addenbrookes Hospital	Cambridge	United Kingdom	2